Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study

PURPOSE: This study aimed to assess the efficacy and safety of adjuvant transarterial chemoembolization (TACE) plus tyrosine kinase inhibitor (TKI) treatment in patients with hepatocellular carcinoma (HCC) with a high risk of early recurrence after curative resection. PATIENTS AND METHODS: Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Kongying, Wei, Fuqun, Huang, Qizhen, Lai, Zisen, Zhang, Jinyu, Chen, Qingjing, Jiang, Yabin, Kong, Jie, Tang, Shichuan, Lin, Jianhuai, Chen, Yufeng, Chen, Jinhong, Zeng, Yongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922443/
https://www.ncbi.nlm.nih.gov/pubmed/35300207
http://dx.doi.org/10.2147/JHC.S352480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922443/
https://www.ncbi.nlm.nih.gov/pubmed/35300207
http://dx.doi.org/10.2147/JHC.S352480

Ejemplares similares